€190.40
0.83% today
Paris, Nov 04, 05:35 pm CET
ISIN
FR0013154002
Symbol
DIM
Sector

Sartorius Stedim Biotech Target price 2024 - Analyst rating & recommendation

Sartorius Stedim Biotech Classifications & Recommendation:

Buy
64%
Hold
29%
Sell
7%

Sartorius Stedim Biotech Price Target

Target Price €222.64
Price €190.40
Potential
Number of Estimates 14
14 Analysts have issued a price target Sartorius Stedim Biotech 2025 . The average Sartorius Stedim Biotech target price is €222.64. This is higher than the current stock price. The highest price target is
€310.00 62.82%
register free of charge
, the lowest is
€134.00 29.62%
register free of charge
.
A rating was issued by 14 analysts: 9 Analysts recommend Sartorius Stedim Biotech to buy, 4 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Sartorius Stedim Biotech stock has an average upside potential 2025 of . Most analysts recommend the Sartorius Stedim Biotech stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Billion € 2.78 2.76
20.53% 0.44%
EBITDA Margin 26.02% 27.54%
29.17% 5.85%
Net Margin 11.78% 8.51%
55.54% 27.77%

13 Analysts have issued a sales forecast Sartorius Stedim Biotech 2024 . The average Sartorius Stedim Biotech sales estimate is

€2.8b
Unlock
. This is
1.02% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
€2.8b 3.02%
Unlock
, the lowest is
€2.7b 0.30%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 €2.8b 20.53%
2024
€2.8b 0.44%
Unlock
2025
€3.0b 8.93%
Unlock
2026
€3.4b 11.39%
Unlock
2027
€3.8b 12.43%
Unlock
2028
€4.3b 13.88%
Unlock

13 Analysts have issued an Sartorius Stedim Biotech EBITDA forecast 2024. The average Sartorius Stedim Biotech EBITDA estimate is

€761m
Unlock
. This is
19.35% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
€792m 24.17%
Unlock
, the lowest is
€703m 10.26%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 €722m 43.71%
2024
€761m 5.39%
Unlock
2025
€891m 17.07%
Unlock
2026
€1.0b 16.67%
Unlock
2027
€1.2b 14.61%
Unlock
2028
€1.4b 17.86%
Unlock

EBITDA Margin

2023 26.02% 29.17%
2024
27.54% 5.85%
Unlock
2025
29.60% 7.48%
Unlock
2026
31.00% 4.73%
Unlock
2027
31.60% 1.94%
Unlock
2028
32.70% 3.48%
Unlock

12 Sartorius Stedim Biotech Analysts have issued a net profit forecast 2024. The average Sartorius Stedim Biotech net profit estimate is

€235m
Unlock
. This is
37.36% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
€344m 100.57%
Unlock
, the lowest is
€178m 4.13%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 €327m 64.67%
2024
€235m 28.05%
Unlock
2025
€343m 45.84%
Unlock
2026
€450m 31.05%
Unlock
2027
€571m 27.00%
Unlock
2028
€722m 26.36%
Unlock

Net Margin

2023 11.78% 55.54%
2024
8.51% 27.77%
Unlock
2025
11.40% 33.96%
Unlock
2026
13.41% 17.63%
Unlock
2027
15.15% 12.98%
Unlock
2028
16.81% 10.96%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share 3.36 2.42
64.67% 27.98%
P/E 79.42
EV/Sales 7.62

12 Analysts have issued a Sartorius Stedim Biotech forecast for earnings per share. The average Sartorius Stedim Biotech <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

€2.42
Unlock
. This is
37.50% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
€3.53 100.57%
Unlock
, the lowest is
€1.83 3.98%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 €3.36 64.67%
2024
€2.42 27.98%
Unlock
2025
€3.53 45.87%
Unlock
2026
€4.62 30.88%
Unlock
2027
€5.87 27.06%
Unlock
2028
€7.42 26.41%
Unlock

P/E ratio

Current 108.91 225.88%
2024
79.42 27.08%
Unlock
2025
54.46 31.43%
Unlock
2026
41.55 23.71%
Unlock
2027
32.72 21.25%
Unlock
2028
25.89 20.87%
Unlock

Based on analysts' sales estimates for 2024, the Sartorius Stedim Biotech stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 7.70 19.94%
2024
7.62 0.98%
Unlock
2025
7.00 8.20%
Unlock
2026
6.28 10.22%
Unlock
2027
5.59 11.05%
Unlock
2028
4.91 12.19%
Unlock

P/S ratio

Current 6.83 32.45%
2024
6.76 1.01%
Unlock
2025
6.21 8.20%
Unlock
2026
5.57 10.23%
Unlock
2027
4.96 11.05%
Unlock
2028
4.35 12.19%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today